CD8A and lung cancer: Moreover, using DC-based HHP lung cancer vaccine generated from NSCLC patients we observed an increase in proliferation and IFN-γ production in CD8+ and CD4+ T cells over the T cells stimulated with patient’s DC-treated with poly(I:C) only.